Pyxis Partners and Rx4good Unite to Guide Biopharmaceutical Companies in Diversifying Clinical Trials
Diversity action plan requirements, when finalized by FDA, will improve inclusion of communities historically underrepresented in medical research. Washington, DC (March 5, 2024) – Recently members of the Congressional Committee…